NOT FOR REPRINT

Page printed from: https://www.chinalawandpractice.com/2024/05/17/national-medical-products-administration-announcement-on-matters-relating-to-optimizing-the-application-for-registration-of-the-marketing-of-a-domestically1-marketed-foreign2-produced-pharmaceutical

• Foreign Direct Investment
• Law Digest
• Legislation
• Retail Trade and Distribution
• Technology Media and Telecom

National Medical Products Administration, Announcement on Matters Relating to Optimizing the Application for Registration of the Marketing of a Domestically Marketed Foreign Produced Pharmaceutical the Production of Which is to Switch to Mainland China

国家药监局关于优化已在境内上市的境外生产药品转移至境内生产的药品上市注册申请相关事项的公告

Share: